Sartorius Stedim Biotech Management
Management Kriterienprüfungen 2/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Rene Faber
Geschäftsführender
€790.0k
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 68.4% |
| Amtszeit als Geschäftsführer | 1.7yrs |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | keine Daten |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 8.4yrs |
Jüngste Management Updates
Recent updates
Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 25
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up
Oct 15Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 11Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 21Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Jul 12Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For
Apr 20Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)
Feb 19Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear
Dec 22Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Nov 10Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching
May 09Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Apr 23Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?
Jan 20Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today
Oct 20Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Oct 03We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?
Jul 09Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 21Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Apr 21Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock
Apr 03We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit
Feb 24Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | €161m |
| Jun 30 2024 | n/a | n/a | €170m |
| Mar 31 2024 | n/a | n/a | €255m |
| Dec 31 2023 | €790k | €540k | €310m |
| Sep 30 2023 | n/a | n/a | €460m |
| Jun 30 2023 | n/a | n/a | €635m |
| Mar 31 2023 | n/a | n/a | €717m |
| Dec 31 2022 | €578k | €288k | €876m |
| Sep 30 2022 | n/a | n/a | €681m |
| Jun 30 2022 | n/a | n/a | €625m |
| Mar 31 2022 | n/a | n/a | €559m |
| Dec 31 2021 | €901k | €396k | €414m |
| Sep 30 2021 | n/a | n/a | €523m |
| Jun 30 2021 | n/a | n/a | €469m |
| Mar 31 2021 | n/a | n/a | €398m |
| Dec 31 2020 | €742k | €396k | €336m |
| Sep 30 2020 | n/a | n/a | €299m |
| Jun 30 2020 | n/a | n/a | €255m |
| Mar 31 2020 | n/a | n/a | €254m |
| Dec 31 2019 | €784k | €425k | €235m |
Vergütung im Vergleich zum Markt: ReneDie Gesamtvergütung ($USD831.67K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt French ($USD4.61M).
Entschädigung vs. Einkommen: ReneDie Bezüge der Mitarbeiter sind um mehr als 20 % gestiegen, während die Unternehmensgewinne im vergangenen Jahr um mehr als 20 % gesunken sind.
Geschäftsführer
Rene Faber (49 yo)
1.7yrs
Amtszeit
€790,000
Vergütung
Dr. Rene Faber serves as Head of Bioprocess Solutions Division and Member of the Executive Board at Sartorius Aktiengesellschaft since January 01, 2019. He serves as Chief Executive Officer at Sartorius St...
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & DIrector | 5.7yrs | €790.00k | keine Daten | |
| Non-Executive & Non-Independent Chairman | 17.4yrs | €693.15k | 0.000010% € 1.6k | |
| Director | 7.2yrs | €84.00k | 0% € 0 | |
| Director | 17.4yrs | €56.00k | 0.000010% € 1.6k | |
| Independent Director | 5.7yrs | €93.00k | 0% € 0 | |
| Lead Independent Director | 9.6yrs | €91.00k | 0.000010% € 1.6k | |
| Independent Director | 9.6yrs | €84.00k | 0.000010% € 1.6k | |
| Employee Representative Non - Executive Director | 1.1yrs | keine Daten | 0% € 0 |
8.4yrs
Durchschnittliche Betriebszugehörigkeit
61yo
Durchschnittliches Alter
Erfahrener Vorstand: DIMDie Vorstandsmitglieder gelten als erfahren (8.4 Jahre durchschnittliche Amtszeit).